The aim of this study was to test the hypothesis that cannabidiol could reduce daily perceived stress among people experiencing elevated levels of COVID-19–related perceived stress, in addition to levels of nonspecific anxiety and distress.

Data continue to emerge on the use of cannabinoids for pain management, narcotic substitution, and heroin withdrawal. Building on previous studies, I present a case demonstrating the effectiveness of dose-controlled, oral cannabinoids to rapidly remove prescription opioids using cannabis substitution therapy.

Medical cannabis may play an important role in the management of fibromyalgia and associated symptoms of depression and anxiety. Further studies are needed to support the use of medical cannabis in patients with fibromyalgia.

The aim of this observational study was to measure the HRQoL for 1 year of 60 participants who used medical cannabis products primarily to manage their anxiety symptoms. 
 

We describe a case of a 27-year-old man with an 8-year history of severe OUD achieving successful transition to naltrexone-based abstinence maintenance therapy following cessation of methadone using an intervention of highly purified, high-dose CBD.

he aim of this study was to evaluate the effect of a repeat-action tablet containing 10 mg THC and 5 mg CBN on sleep quality, sleep duration, and awakenings in participants (medical cannabis users). The effect of the combination tablet was evaluated using objectively measured and self-reported data.

Although CBD products are generally recognized as effective and safe, potential safety concerns exist that may go unaddressed. This study demonstrates that pharmacists, who are one of the most accessible health care professionals, can serve as a valuable resource to patients regarding the safe use of CBD products.

Introduction With the rising incidence of non-melanoma skin cancer, there is a need for exploring alternative and noninvasive treatment options.1 Estimates show that about 3% to 5% of squamous cell carcinoma in situ (SCCis) cases, also known as Bowen’s disease, progress to invasive disease. A retrospective analysis of 239 patients concluded that although excisional surgery…

Introduction Although oral cannabidiol (CBD) formulations are increasingly popular, studies show that oral CBD has a much lower bioavailability than inhaled CBD.1 This study was designed to compare the bioavailability of 2 different preparations of oral CBD, with and without a liposomal delivery system. Puffin Hemp has a patent-pending liposome manufacturing technology that is used…

We present a case report of a patient who was guided through 2 postsurgical opioid wean programs. The opioid wean after the first surgery did not include medical cannabis whereas the opioid wean after the second surgery did; the difference in symptoms is striking.